155 related articles for article (PubMed ID: 23599598)
1. Coexisting iodine avid and iodine nonconcentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer.
Mohapatra T; Arora A; Bethune NN
Indian J Nucl Med; 2012 Jan; 27(1):38-41. PubMed ID: 23599598
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and functional imaging employment in the differentiation of brown tumors from bone metastases in a case of primary papillary thyroid cancer and parathyroid adenoma: case report.
Al-Rasheed U; Barakat F; Al-Ibraheem A
J Egypt Natl Canc Inst; 2021 Oct; 33(1):30. PubMed ID: 34657985
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic clue of nodular fasciitis mimicking metastasis in papillary thyroid cancer, mismatching findings on
Seo M; Kim M; Kim ES; Sim H; Jun S; Park SH
Oncol Lett; 2017 Jul; 14(1):1167-1171. PubMed ID: 28693291
[TBL] [Abstract][Full Text] [Related]
4. Multiple Simultaneous Rare Distant Metastases as the Initial Presentation of Papillary Thyroid Carcinoma: A Case Report.
Yang J; Ma Y; Gong Y; Gong R; Li Z; Zhu J
Front Endocrinol (Lausanne); 2019; 10():759. PubMed ID: 31781034
[TBL] [Abstract][Full Text] [Related]
5. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Hung MC; Wu HS; Kao CH; Chen WK; Changlai SP
Endocr Res; 2003 May; 29(2):169-75. PubMed ID: 12856803
[TBL] [Abstract][Full Text] [Related]
6. Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib.
Jafri S; Yaqub A
Cureus; 2021 Aug; 13(8):e17488. PubMed ID: 34595070
[TBL] [Abstract][Full Text] [Related]
7. Calcaneus metastasis: a rare presentation of poorly differentiated thyroid cancer.
Elshafie O; Jain A; Bichpuria S; Rassou Y; Hashmi SF; Bou Khalil A
Endocrinol Diabetes Metab Case Rep; 2023 Oct; 2023(4):. PubMed ID: 38054478
[TBL] [Abstract][Full Text] [Related]
8. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
[TBL] [Abstract][Full Text] [Related]
9. Isolated skeletal muscle metastatic deposit in a patient with micropapillary carcinoma thyroid identified by 18F FDG PET CT.
Sarma M; Sonik B; Subramanyam P; Sundaram PS
J Egypt Natl Canc Inst; 2015 Mar; 27(1):47-50. PubMed ID: 25698468
[TBL] [Abstract][Full Text] [Related]
10. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
Muros MA; Llamas-Elvira JM; Ramírez-Navarro A; Gómez MJ; Rodríguez-Fernández A; Muros T; López de la Torre M; Becerra A; Carreras JL
Am J Surg; 2000 Jun; 179(6):457-61. PubMed ID: 11004330
[TBL] [Abstract][Full Text] [Related]
11. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
Küçük ON; Gültekin SS; Aras G; Ibiş E
Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
16. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.
Gezer E; Selek A; Tarkun İ; Cantürk Z; Çetinarslan B
J Med Case Rep; 2019 Apr; 13(1):95. PubMed ID: 31003598
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
Samanci C; Onal Y; Sager S; Asa S; Ustabasioglu FE; Alis D; Akman C; Sonmezoglu K
Curr Med Imaging Rev; 2019; 15(10):956-964. PubMed ID: 32008523
[TBL] [Abstract][Full Text] [Related]
19. Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid.
Malhotra G; Upadhye TS; Sridhar E; Asopa RV; Garde PS; Gawde S; Rangarajan V
Clin Nucl Med; 2010 Sep; 35(9):731-6. PubMed ID: 20706057
[TBL] [Abstract][Full Text] [Related]
20. Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.
Rendl G; Rettenbacher L; Schweighofer-Zwink G; Hehenwarter L; Pirich C
Horm Metab Res; 2020 Mar; 52(3):158-167. PubMed ID: 32215887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
